Early Treatment with New Drug Shows Promising Motor Improvements in Young Boys with Duchenne Muscular Dystrophy
Photo: Victor Freitas / Unsplash
Researchers studying the drug Vamorolone have found that treating very young boys with Duchenne muscular dystrophy earlier—potentially before major symptoms appear—can lead to significant motor improvements in just 12 weeks. This discovery offers a hopeful new avenue for managing the progressive genetic disorder and improving the long-term quality of life for affected children.
Researchers studying the drug Vamorolone have found that treating very young boys with Duchenne muscular dystrophy earlier—potentially before major symptoms appear—can lead to significant motor improvements in just 12 weeks. This discovery offers a hopeful new avenue for managing the progressive genetic disorder and improving the long-term quality of life for affected children.